View of PRELIMINARY ASSESSMENT OF THE EFFICACY OF RUXOLITINIB TREATMENT IN PRIMARY MYELOFIBROSIS PATIENTS AT THE NATIONAL INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION FROM 2019 TO 2024

Return to Article Details PRELIMINARY ASSESSMENT OF THE EFFICACY OF RUXOLITINIB TREATMENT IN PRIMARY MYELOFIBROSIS PATIENTS AT THE NATIONAL INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION FROM 2019 TO 2024 Download Download PDF